Meeting the transfusion needs of a patient with anti-Ena requires an international effort

References

1. Ratliff J, Veneman S, Ward S, et al. An alloantibody to a high-prevalence MNS antigen in a person with a GP.JL/Mk phenotype. Immunohematology 2007;23:146–9.
Search in Google Scholar Back to article
2. Howard PJ, Guerra L, Kuttner DK, George MR. Clinical approach after identification of a rare anti-En^a in a prenatal sample. Immunohematology 2019;35:159–61.
Search in Google Scholar Back to article
3. Walker PS, Bergren MO, Busch MP, Carmody AM, Perkins HA. Finnish En(a–) propositus with anti-EnaFS and anti-EnaFR: in vitro and in vivo characteristics. Vox Sang 1987;52:103–6.
Search in Google Scholar Back to article
4. Nance SJ, Lomas-Francis C; ISBT Working Party on Rare Donors. Where in the world are rare donors? A Working Party On Rare Donors Survey. Vox Sang 2020;115(Suppl 1):91.
Search in Google Scholar Back to article
5. Nance S, VanThof L, Kaherl K, et al. Survey of the American Rare Donor Program: new insights into enumerating rare donors and rare blood requests in the USA (abstract). Transfusion 2021;61(Suppl 3):17A.
Search in Google Scholar Back to article